Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Marmorstein

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Biological Chemistry|May 30, 2024
ACLY alternative splicing correlates with cancer phenotypesJulianna G Supplee, Hayley C Affronti, Richard Duan, et al.
Human Molecular Genetics|December 10, 2014
Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defectsLine M Myklebust, Petra Van Damme, Svein I Støve, et al.
The Journal of Biological Chemistry|October 29, 2021
The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activationMichael Grasso, Gavin J Bond, Ye-Jin Kim, et al.
Nature Aging|January 24, 2024
TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammationXue Hao, Bo Zhao, Martina Towers, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2021
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferasesZhiqin Ji, Richard F Clark, Vikram Bhat, et al.
Cancer Research|February 28, 2024
Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell CarcinomaRomain Riscal, Sarah M Gardner, Nathan J Coffey, et al.
Chemistry & Biology|June 11, 2010
Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitorErin M Bowers, Gai Yan, Chandrani Mukherjee, et al.
Biochemistry|December 4, 2020
Identification and Characterization of a B-Raf Kinase α-Helix Critical for the Activity of MEK Kinase in MAPK SignalingDiep Nguyen, Linda Yingqi Lin, Jeffrey O Zhou, et al.
Nature|November 3, 2015
Autophagy mediates degradation of nuclear laminaZhixun Dou, Caiyue Xu, Greg Donahue, et al.
ACS Medicinal Chemistry Letters|January 20, 2018
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone AcetyltransferasesMichael R Michaelides, Arthur Kluge, Michael Patane, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Biological Chemistry|May 30, 2024
ACLY alternative splicing correlates with cancer phenotypesJulianna G Supplee, Hayley C Affronti, Richard Duan, et al.
Human Molecular Genetics|December 10, 2014
Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defectsLine M Myklebust, Petra Van Damme, Svein I Støve, et al.
The Journal of Biological Chemistry|October 29, 2021
The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activationMichael Grasso, Gavin J Bond, Ye-Jin Kim, et al.
Nature Aging|January 24, 2024
TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammationXue Hao, Bo Zhao, Martina Towers, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2021
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferasesZhiqin Ji, Richard F Clark, Vikram Bhat, et al.
Cancer Research|February 28, 2024
Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell CarcinomaRomain Riscal, Sarah M Gardner, Nathan J Coffey, et al.
Chemistry & Biology|June 11, 2010
Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitorErin M Bowers, Gai Yan, Chandrani Mukherjee, et al.
Biochemistry|December 4, 2020
Identification and Characterization of a B-Raf Kinase α-Helix Critical for the Activity of MEK Kinase in MAPK SignalingDiep Nguyen, Linda Yingqi Lin, Jeffrey O Zhou, et al.
Nature|November 3, 2015
Autophagy mediates degradation of nuclear laminaZhixun Dou, Caiyue Xu, Greg Donahue, et al.
ACS Medicinal Chemistry Letters|January 20, 2018
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone AcetyltransferasesMichael R Michaelides, Arthur Kluge, Michael Patane, et al.
Pageof 21